CTRI/2024/04/066493Not yet recruitingUnknown
Prevalence of Central Nervous system infections in the COVID 19 and post COVID 19 period - NI
Trial Snapshot
- Phase
- Unknown
- Status
- Not yet recruiting
- Sponsor
- Self sponsored
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
Inclusion Criteria
- •Patients with all age groups (Newborn to 90
- •years old) diagnosed with Central Nervous
- •System infections based on clinical features
- •and initial CSF and neuro-imaging results at
- •Kasturba Hospital, Manipal, between 01
- •November 2020- 31 September 2023
Exclusion Criteria
- •Central Nervous System infections not
- •suspected or criteria for Central Nervous
- •System infections not met.
Investigators
Similar Trials
Completed
Not Applicable
Isolated central nervous system disease in Familial Hemophagocytic Lymphohistiocytosis (FHL) – a case seriesD76.1Haemophagocytic lymphohistiocytosisDRKS00013196niversitätsklinikum Freiburg Centrum für Chronische Immundefizienz (CCI) im Zentrum für Translationale Zellforschung38
Withdrawn
Not Applicable
Infections of the Central Nervous SystemAdult Patients With Suspected Meningitis and/or EncephalitisNCT03856528University Hospital, Basel, Switzerland500
Completed
Not Applicable
Incidence of transient neurologic symptom following intrathecal anesthesia with lidocaine in cesarean and factors affecting it.Transient neuorologic syndrom.Other transient cerebral ischaemic attacks and related syndromesIRCT201404211616N4Kermanshah University of Medical Sciences, Research Department60
Recruiting
Not Applicable
CNS Vasculitis RegistryCTRI/2018/03/012721AIIMS New Delhi
Completed
Not Applicable
Early diagnosis of central nervous system involvement of malignant lymphoma by multiplex PCR methodMalignant LymphomaJPRN-UMIN000004521Yokohama City University Hospital80
